phenylacetic acid has been researched along with Chronic Kidney Failure in 7 studies
phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Phenylacetic acid (PAA) is a recently described uremic toxin that inhibits inducible nitric oxide synthase expression and plasma membrane calcium ATPase and may therefore also be involved in remodeling of arteries." | 1.34 | Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy. ( Haass, W; Henning, L; Jankowski, J; Jankowski, V; Scholze, A; Suvd-Erdene, S; Tepel, M; Wittstock, A; Zidek, W, 2007) |
| "Paraoxonase is an esterase that hydrolyzes organophosphate compounds." | 1.30 | Decrease of serum paraoxonase activity in chronic renal failure. ( Charmes, JP; Dantoine, TF; Debord, J; Lachatre, G; Leroux-Robert, C; Marquet, P; Merle, L, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henning, BF | 1 |
| Holzhausen, H | 1 |
| Tepel, M | 3 |
| Morita, M | 1 |
| Yano, S | 2 |
| Yamaguchi, T | 2 |
| Yamauchi, M | 2 |
| Sugimoto, T | 2 |
| Jankowski, J | 3 |
| van der Giet, M | 2 |
| Jankowski, V | 3 |
| Schmidt, S | 2 |
| Hemeier, M | 1 |
| Mahn, B | 1 |
| Giebing, G | 1 |
| Tolle, M | 1 |
| Luftmann, H | 1 |
| Schluter, H | 1 |
| Zidek, W | 3 |
| Scholze, A | 1 |
| Henning, L | 1 |
| Haass, W | 1 |
| Wittstock, A | 1 |
| Suvd-Erdene, S | 1 |
| Kanazawa, I | 1 |
| Ogawa, N | 1 |
| Hayashi, K | 1 |
| Westhoff, TH | 1 |
| Krauser, P | 1 |
| Ignatius, R | 1 |
| Dantoine, TF | 1 |
| Debord, J | 1 |
| Charmes, JP | 1 |
| Merle, L | 1 |
| Marquet, P | 1 |
| Lachatre, G | 1 |
| Leroux-Robert, C | 1 |
7 other studies available for phenylacetic acid and Chronic Kidney Failure
| Article | Year |
|---|---|
Continuous reduction of plasma paraoxonase activity with increasing dialysis vintage in hemodialysis patients.
Topics: Analysis of Variance; Aryldialkylphosphatase; Cross-Sectional Studies; Esterases; Female; Humans; Ki | 2010 |
Phenylacetic acid stimulates reactive oxygen species generation and tumor necrosis factor-α secretion in vascular endothelial cells.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aorta; Cells, Cultured; Deoxyguanosine; Dose-Response Relationship, Dru | 2011 |
Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.
Topics: Adult; Aged; Animals; Blotting, Western; Cell Line; Cell Survival; Cells, Cultured; Dose-Response Re | 2003 |
Phenylacetic acid and arterial vascular properties in patients with chronic kidney disease stage 5 on hemodialysis therapy.
Topics: Aged; Arteries; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Phenylacetates; | 2007 |
The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure.
Topics: 3T3 Cells; Animals; Bone and Bones; Calcification, Physiologic; Cell Differentiation; Cell Division; | 2007 |
The uraemic toxin phenylacetic acid impairs macrophage function.
Topics: Adult; Animals; Cell Line; Extracellular Signal-Regulated MAP Kinases; Humans; Kidney Failure, Chron | 2008 |
Decrease of serum paraoxonase activity in chronic renal failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Aryldialkylphosphatase; Esterases; Fem | 1998 |